The genesis and evolution of high-grade serous ovarian cancer
- PMID: 20944665
- DOI: 10.1038/nrc2946
The genesis and evolution of high-grade serous ovarian cancer
Abstract
Germline mutation in either BRCA1 or BRCA2 is associated with an increased risk of ovarian cancer, particularly the most common invasive histotype - serous carcinoma. In addition, serous ovarian cancers have an unusually high frequency of other molecular events involving BRCA pathway dysfunction. Recent findings show a high frequency of TP53 mutation, chromosomal instability, distinct molecular subtypes and DNA copy number-driven changes in gene expression. These findings suggest a model in which homologous recombination repair deficiency initiates a cascade of molecular events that sculpt the evolution of high-grade serous ovarian cancer and dictate its response to therapy.
Comment in
-
The forgotten fallopian tube.Nat Rev Cancer. 2011 Mar;11(3):227; author reply 227. doi: 10.1038/nrc2946-c1. Nat Rev Cancer. 2011. PMID: 21326326 No abstract available.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous